TBPH
Theravance Biopharma Inc
17.00$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +12.3% | +4.3% | +29.1% | -21.4% | +96.3% | +45.8% | -5.1% | -18.3% | -39.4% | -15.1% | +56.0% | |
| – | +25.0% | -23.8% | +19.4% | +4.4% | +17.8% | +4.2% | -1.5% | -36.0% | -36.1% | -15.7% | -13.6% | |
| – | +22.3% | -25.7% | +39.0% | -21.9% | +34.0% | +29.3% | -72.6% | -773.9% | – | – | – | |
| – | -395.9% | – | -52.2% | +164.9% | -176.4% | – | – | – | -119.7% | – | +491.8% | |
| – | -14.8% | -19.3% | +12.7% | +200.9% | -56.1% | +108.3% | -48.5% | -83.2% | +335.0% | -86.7% | -87.3% | |
| – | – | -233.5% | -62.0% | – | -147.0% | – | +1,061.2% | +827.0% | -102.8% | – | -957.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +324.7% | +412.0% | +121.1% | +14.6% | -67.6% | +207.2% | -7.1% | +1,359.9% | +50.9% | -98.4% | +30.0% | |
| – | +0.0% | +0.0% | +3.1% | +0.0% | -100.9% | – | -108.4% | +5,786.3% | -100.0% | – | – | |
| – | -78.1% | +489.4% | -99.7% | +13,499.0% | -99.4% | +20,278.4% | -65.1% | -926.0% | -73.8% | -98.7% | +30.1% | |
| – | -93.7% | +887.6% | -210.2% | – | -210.7% | – | -63.7% | +2,350.7% | -224.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.